Records containing: Renal Impairment
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-09-11Evaluation of Non-Surgical Venous Thromboembolism Prophylaxis Dosing Strategies: Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function
-
CLINICAL_TRIALS study record update · 2017-08-18A Single Dose Evaluation of the Effects of Renal Impairment on Deflazacort Pharmacokinetics
-
CLINICAL_TRIALS study record update · 2017-08-10Phase I Open-label, Parallel-group, Comparative Study to Evaluate the Effects of Renal or Hepatic Impairment on TAK-272 Pharmacokinetics With a Single Oral Administration of TAK-272 in Patients With Renal or Hepatic Impairment
-
CLINICAL_TRIALS study record update · 2017-07-27An Open-label Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment
-
CLINICAL_TRIALS study record update · 2017-04-04An Open-label Trial Investigating the Pharmacokinetics and the Tolerability of NN9535 in Subjects With Normal Renal Function and Various Degrees of Impaired Renal Function
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-03-03A Two Part, Open-label, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-7145 in Patients With Renal Insufficiency (Part I) and Heart Failure With Renal Insufficiency (Part II)
-
CLINICAL_TRIALS study record update · 2016-12-06An Open-label, Non-randomized, Parallel-group Design Clinical Trial for Comparative Evaluation of Pharmacokinetics After CKD-501 Between Patients With Renal Impairment and Control Subjects With Normal Renal Function
-
CLINICAL_TRIALS study record update · 2016-11-08An Interventional, Single-site, Open-label, Four-group, Single-dose Study Investigating the Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment (Mild, Moderate, or Severe) and in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2016-10-27A Randomized Controlled Trial of Renal Hypothermia During Partial Nephrectomy
-
CLINICAL_TRIALS study record update · 2016-09-19The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Diseases. An Observational Biomarker Study
-
CLINICAL_TRIALS study record update · 2016-08-26ClinicalTrials.gov study NCT02709382
-
CLINICAL_TRIALS study record update · 2016-06-17An Open-label, Non-randomized, Monocenter, Single-dose, Phase I Study to Evaluate Pharmacokinetics and Safety of POL7080 Administered as Single Intravenous Infusion to Subjects With Renal Impairment
-
CLINICAL_TRIALS study record update · 2016-05-25Prematurity as Predictor of Children's Cardiovascular-renal Health (PREMATCH)
-
CLINICAL_TRIALS study record update · 2016-05-03A Phase I Open-Label Study With 200 mg Intravenous TR-701 Free Acid to Assess Safety and Pharmacokinetics in Advanced Renal Impairment Subjects
-
CLINICAL_TRIALS study record update · 2016-03-08Effects of Cardiopulmonary Bypass on Urinary Secretion of NAG
-
CLINICAL_TRIALS study record update · 2016-03-04An Open-Label Study to Investigate the Pharmacokinetics of MK-5172 and MK-8742 in Subjects With Renal Insufficiency
-
CLINICAL_TRIALS study record update · 2016-02-22Evaluation of the Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function
-
CLINICAL_TRIALS study record update · 2016-02-19An Open-label Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg Administered Subcutaneously in Subjects With Severe Chronic Kidney Disease (CKD) and CKD on Dialysis
-
CLINICAL_TRIALS study record update · 2016-02-18Prospective Non-randomized (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Gadovist in Patients With Moderate to Severe Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information
-
CLINICAL_TRIALS study record update · 2016-02-04A Phase 1 Study of the Pharmacokinetics, Safety, and Tolerability of ALKS5461 in Subjects With Renal Impairment
-
CLINICAL_TRIALS study record update · 2016-01-28An Open-Label Pharmacokinetic and Pharmacodynamic Study of a Single Dose of IDN-6556 in Subjects With Severe Renal Impairment and in Matched Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2016-01-13Non-Interventional Observation Trial to Investigate the Efficacy, Safety and Usability of Mircera in PD Patients in Daily Use
-
CLINICAL_TRIALS study record update · 2015-08-27A Clinical Study to Investigate the Pharmacokinetics/Pharmacodynamics and Tolerability of DA-1229(Evogliptin) Tablet in Renal Impaired Patients
-
CLINICAL_TRIALS study record update · 2015-08-26A Multi-Center, Open-Label Phase I Study to Investigate the Effect of Different Degrees of Renal Impairment on the Single-Dose Pharmacokinetics of EVP-6124 in Patients With Renal Impairment Compared to Subjects With Normal Renal Function
-
CLINICAL_TRIALS study record update · 2015-07-27Phase 1, Non-Randomized, Parallel-Group, Open-Label Study to Characterize the Pharmacokinetics of a Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment Compared to Healthy Subjects